Morning Edition — September 18, 2026

⚡ The Fed Just Raised Rates — And Trump Isn't Happy
Kevin Warsh's Fed raised its benchmark rate a quarter point to 3.75%–4% on Wednesday — the first hike since 2023, and the first policy move of Warsh's own chairmanship. It lands directly on your own balance sheet: the cost of borrowing, the yield on cash and CDs, and the market's read on where rates sit in 2027 all just repriced at once.
Trump had been publicly lobbying for cuts and shows no sign of backing off — even though Warsh was his own pick to run the Fed, the White House is now warning of a full-blown ‘Fed independence’ fight. Warsh's own line: ‘the plain fact is that inflation is too high and has been for too long,’ with Fed officials signaling at least one more hike is likely before year-end.
Stocks sold off Wednesday as Treasury yields spiked to 19-year highs, then ripped back Thursday once yields eased — the Standard and Poor's 500 gained 1.14% and the Nasdaq climbed 1.69%. The real headline isn't the quarter point, it's the precedent: a Fed chair willing to defy the president who appointed him is a new dynamic, and it likely means more volatility around every rate decision from here to the next election cycle.

A Seven-Run Second Sinks Rockies Again — 10th Loss in 11 Games
Thursday's version of the collapse: a seven-run second inning by San Diego turned a close game into a laugher, and the Rockies fell 9-2, their tenth loss in their last eleven. At this point in a lost season, the box score matters less than what's still standing underneath it.
The real story in Denver all year has been Hunter Goodman, who leads all of baseball with 23 road home runs and 38 total — legitimate, career-arc production buried inside a losing record. Rookies TJ Rumfield (a homer) and Cole Carrigg (a triple) flashed in a recent loss to St. Louis, and pitching prospect Mason Adams struck out five over five innings in his own outing — the reasons to keep half an eye on September baseball in Colorado.
GM Josh Byrnes put words to the tension every Rockies fan feels right now: ‘you can't be so future-focused that you're not trying to win every day’ — a balance the front office will be litigating all winter. On the injury side, Jose Quintana and Kyle Freeland both threw scoreless rehab innings in Double-A, which counts as good news these days.

A Two-Run Homer, a Near-Cycle, and a Division Title
Kyle Tucker's night in the desert of Ohio headlined the evening — but it was a night full of statement performances across a slate that thinned out for an off day around the league.
Kyle Tucker hit a two-run homer and came a triple short of the cycle as the Dodgers clinched their fifth straight NL West title with an 8-2 win over Cincinnati. The Angels blew a ninth-inning lead, then walked it off in the 10th on Wade Meckler's single after Mike Trout tied it with an RBI single of his own. The White Sox held Detroit to one run and climbed back into a share of the AL Central lead — a division that's changed hands almost nightly. A shutout of the Mets kept Philadelphia's wild-card push alive at exactly the moment it needed one. The one to forget: a seven-run second inning by San Diego turned a winnable game into Colorado's tenth loss in eleven.

The American League's Stretch Run Just Got Weird
Tampa Bay has the AL East essentially wrapped up, sitting comfortably out front with the division's best record all September — Thursday's blowout of the Athletics just padded the margin. The Yankees have long since punched their ticket to October too, holding down the top AL wild-card slot with enough cushion that a recent extra-innings loss to Minnesota barely moved the needle.
Everything else is live, and the AL Central is the best example: it's changed hands more than once in the last 48 hours alone, with Cleveland and Chicago trading first place practically day to day — Thursday's edition went to the White Sox, who beat Detroit to move back into a share of the lead. Out west, Houston and Texas have been locked in the same kind of dead heat, tied or a fraction of a game apart for over a week; Houston's win over Kansas City on Thursday kept it that way heading into the final stretch.
Behind the Yankees, the last two AL wild-card spots remain a genuine scrum among the Red Sox, White Sox and Rangers, separated by a handful of games with less than two weeks to play. Nobody in that group is safe, and nobody's out — the kind of race that will likely still be live on the season's final weekend.

Dodgers Pop the Champagne; NL Wild Card Is Still a Demolition Derby
One division race ended Thursday: the Dodgers clinched the NL West — their fifth straight title, and their 13th in the last 14 seasons — beating Cincinnati 8-2 behind a huge night from Kyle Tucker. Milwaukee wrapped up the NL Central weeks earlier and still owns the best record in baseball. That's two of three NL divisions decided with two weeks still to play.
Atlanta's NL East lead is the one still open, though the Braves caught a breather Thursday with a scheduled day off — no games, no change at the top.
The NL wild card remains the tightest race anywhere in baseball: the Cubs, Phillies and Padres have been separated by half-games for over a week. Philadelphia kept pace Thursday with a shutout of the Mets, and San Diego did too, blowing the game open early against Colorado — both results that matter more for the standings than the final score. With the Diamondbacks fading, this is now essentially a three-team fight for what looks like two spots, and it should stay that way into the final week.

Wall Street Just Wrote AI's Biggest Loan Yet
A ten-bank consortium is lending Crux AI — the joint venture Blackstone and Alphabet built to finance AI data centers — $22 billion to buy Google's custom TPU chips. The debt is backed by the chips themselves plus Crux's customer contracts, on top of the $5 billion in equity Blackstone already put in. Banks plan to eventually swap the loan for investment-grade bonds once it's syndicated out.
This is a genuinely new kind of financing: banks underwriting a chip purchase the way they'd underwrite a factory or a pipeline. Crux is targeting its first 500 megawatts of AI capacity online by 2027, aimed at enterprise and government customers who need dedicated compute of their own.
For anyone tracking the AI cycle as more than a stock story, this is the clearest signal yet that the buildout has graduated from tech-company research and development budgets into systemically important infrastructure finance — the kind of capital commitment that's much harder to unwind if the trade turns.

Anthropic Just Talked Its Own Trade Down
Days after that record $22 billion infrastructure loan, Anthropic itself issued a warning that rattled chip stocks — notable precisely because it's coming from inside one of the AI industry's own leading labs, not an outside skeptic. Analysts mostly still think the ‘AI trade’ is structurally intact, and Bloomberg's read is that any drag on chip names is temporary rather than the start of a rout.
Still, the timing is pointed: a record-setting infrastructure financing and a homegrown caution flag landing in the same week, right as Wall Street separately debates whether prospective IPOs from SpaceX, OpenAI and Anthropic itself are running ahead of fundamentals.
Worth watching less for the stock move than as a leading indicator — when the leaders of an industry start hedging in public, that's usually the first crack in a consensus, not the last.

The SEC Just Let Wall Street Go On-Chain
The SEC approved a temporary ‘innovation exemption’ letting U.S. stocks trade on blockchain-based venues, with tokenized shares carrying the same legal rights as ordinary brokerage shares — no synthetic look-alikes allowed, venues restricted to U.S. entities, and the underlying companies given a chance to opt out entirely. SEC Chair Paul Atkins framed it as a step toward ‘vast benefits’ for investors, including something closer to round-the-clock trading.
Nothing changes in your own brokerage account tomorrow morning — the exemption runs five years and no specific trading venues have been named yet. But it's the clearest sign so far that crypto-native market infrastructure is being formally absorbed into the mainstream stock market, worth tracking as venues actually launch and register over the next year.

Moderna's Cancer Bet Just Paid Off — In a Big Way
Moderna stock jumped again Thursday, extending a rally that's now up roughly 137% over the past month, after Moderna and Merck's mRNA cancer vaccine — targeting melanoma — posted strong late-stage trial data. It's a genuinely different approach to cancer treatment: a personalized vaccine trained on the mutations in a patient's own tumor, rather than a one-size-fits-all drug.
Thursday's move, with BioNTech and Novavax also ticking higher, shows how much of the market now believes mRNA's next act is oncology rather than infectious disease.
Given how much of your own life is tied up in cancer research through the Jack Paul Pickleball Open and the Morgan Adams Foundation's work, this is worth filing under ‘the science is actually moving.’ It's a different tumor type and a different company than the pediatric brain-tumor research Morgan Adams funds — but a real proof point for personalized, mutation-targeted vaccines as a treatment class, one that researchers in pediatric oncology are watching just as closely.

Household Incomes Hit a Record. Not Everyone Got the Memo.
New data shows median household income has climbed to a record high — but the gains are lopsided. Higher earners are pulling further ahead while lower-income households are actually losing ground once inflation is factored in.
It's landing alongside an unusually upbeat business mood: CEO confidence just hit a four-year high, with Business Roundtable leadership calling hiring plans ‘encouraging’ even while admitting ‘the broader economic picture remains mixed.’ (The Roundtable also just named Kristen Silverberg, a former U.S. ambassador to the EU, as its next CEO, succeeding Joshua Bolten.)
That gap — record prosperity at the top, real strain further down the ladder — is the fault line to watch heading into next year's economic-policy fights, especially with a Fed that just signaled it isn't done raising rates.